Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rookus, Ma"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 43
Tytuł:
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Autorzy:
Phillips KA
Milne RL
Rookus MA
Goldgar D
Friedlander M
McLachlan SA
Buys S
Antoniou AC
Birch K
Terry MB
Easton DF
Weideman P
Daly M
Andrieu N
John EM
Hooning MJ
Andrulis IL
Caldes T
Olsson H
Hopper JL
Pokaż więcej
Temat:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Genetics
QH426-470
Źródło:
Hereditary Cancer in Clinical Practice, Vol 10, Iss Suppl 2, p A11 (2012)
Opis pliku:
electronic resource
Relacje:
http://www.hccpjournal.com/content/10/S2/A11; https://doaj.org/toc/1897-4287
Dostęp URL:
https://doaj.org/article/ed38b9df8bfd40349652e2b8de972246  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Breast cancer and hormonal contraceptives: further results
Autorzy:
Calle, EE
Heath, CW
Miracle-McMahill, HL
Coates, RJ
Liff, JM
Franceschi, S
Talamini, R
Chantarakul, N
Koetsawang, S
Rachawat, D
Morabia, A
Schuman, L
Stewart, W
Szklo, M
Bain, C
Schofield, F
Siskind, V
Band, P
Coldman, AJ
Gallagher, RP
Hislop, TG
Yang, P
Duffy, SW
Kolonel, LM
Nomura, AMY
Oberle, MW
Ory, HW
Peterson, HB
Wilson, HG
Wingo, PA
Ebeling, K
Kunde, D
Nishan, P
Colditz, G
Martin, N
Pardthaisong, T
Silpisornkosol, S
Theetranont, C
Boosiri, B
Chutivongse, S
Jimakorn, P
Virutamasen, P
Wongsrichanalai, C
McMichael, AJ
Rohan, T
Ewertz, M
Paul, C
Skegg, DCG
Spears, GFS
Boyle, P
Evstifeeva, T
Daling, JR
Malone, K
Noonan, EA
Stanford, JL
Thomas, DB
Weiss, NS
White, E
Andrieu, N
Brêmond, A
Clavel, F
Gairard, B
Lansac, J
Piana, L
Renaud, R
Fine, SRP
Cuevas, HR
Ontiveros, P
Palet, A
Salazar, SB
Aristizabel, N
Cuadros, A
Bachelot, A
Leê, MG
Deacon, J
Peto, J
Taylor, CN
Alfandary, E
Modan, B
Ron, E
Friedman, GD
Hiatt, RA
Bishop, T
Kosmelj, K.
Primic-Zakelj, M
Ravnihar, B
Stare, J
Beeson, WL
Fraser, G
Allen, DS
Bulbrook, RD
Cuzick, J
Fentiman, IS
Hayward, JL
Wang, DY
Hanson, RL
Leske, MC
Mahoney, MC
Nasca, PC
Varma, AO
Weinstein, AL
Moller, TR
Olsson, H
Ranstam, J
Goldbohm, RA
van den Brandt, PA
Apelo, RA
Baens, J
de la Cruz, JR
Javier, B
Lacaya, LB
Ngelangel, CA
La Vecchia, C
Negri, E
Marbuni, E
Ferraroni, M
Gerber, M
Richardson, S
Segala, C
Gatei, D
Kenya, P
Kungu, A
Mati, JG
Brinton, LA
Hoover, R
Schairer, C
Spirtas, R
Lee, HP
Rookus, MA
van Leeuwen, FE
Schoenberg, JA
Gammon, MD
Clarke, EA
Jones, L
McPherson, K
Neil, A
Vessey, M
Yeates, D.
Beral, V
Bull, D
Crossley, B
Hermon, C
Jones, S
Key, T
Reeves, Clewis G
Smith, P
Collins, R
Doll, R
Peto, R
Hannaford, P
Kay, C
Rosero-Bixby, L
Yuan, J-M
Wei, HY
Yun, T
Zhiheng, C
Berry, G
Booth, J Cooper
Jelihovsky, T
Maclennan, R
Shearman, R
Wang, Q-S
Baines, CJ
Miller, AB
Wall, C
Lund, E
Stalsberg, H
Dabancens, A
Martinez, L
Molina, R
Salas, O
Alexander, FE
Hulka, BS
Chilvers, CED
Bernstein, L
Haile, RW
Paganini-Hill, A
Pike, MC
Ross, RK
Ursin, G
Yu, MC
Adami, HO
Bergstrom, R
Longnecker, MP
Farley, TMN
Holck, S
Meirik, O
Pokaż więcej
Źródło:
Contraception; September 1996, Vol. 54 Issue: 3, Number 3 Supplement 1 p1-106, 106p
Periodyk
Szczegóły
Tytuł:
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Autorzy:
Vigorito E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Kuchenbaecker KB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Beesley J; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
Agnarsson BA; Department of Pathology, University Hospital (Landspitali) and University of Iceland School of Medicine, Hringbraut, 101 Reykjavik, Iceland.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Arun BK; Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Anderson Cancer Center, 1515 Pressler Street, CBP 5, Houston, TX, United States of America.
Barjhoux L; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
Belotti M; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
Benitez J; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain, and Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Berger A; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Kabbeltoft 25, Vejle, Denmark.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), via Ripamonti 435, 20141 Milan, Italy.
Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain.
Caligo MA; Section of Genetic Oncology, Dept. of Laboratory Medicine, University and University Hospital of Pisa, Pisa Italy.
Campbell I; Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC 8006, Australia.
Chan SB; 1600 Divisadero Street, C415, San Francisco, CA 94143-1714, United States of America.
Claes KB; Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000 Gent, Belgium.
Cohn DE; Ohio State University Columbus Cancer Council GYN Oncology, 3651 Ridge Mill Drive, Columbus, OH 43026, United States of America.
Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.
Daly MB; Department of Clinical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, United States of America.
Damiola F; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
Davidson R; Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.
Pauw Ad; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
Delnatte C; Unité d'oncogénétique, ICO-Centre René Gauducheau, Boulevard Jacques Monod, 44805 Nantes Saint Herblain Cedex, France.
Diez O; Oncogenetics Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), and Universitat Autònoma, Passeig Vall d'Hebron 119-129, Barcelona, Spain.
Domchek SM; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, United States of America.
Dumont M; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
Dworniczak B; Institute of Human Genetics, University of Münster, Münster, Germany.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Eccles D; University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.
Edwinsdotter Ardnor C; Department of Radiation Sciences, Oncology, Umeå University, Umea, Sweden.
Eeles R; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, United Kingdom.
Evans DG; Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Feliubadalo L; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet, Barcelona, Spain.
Fostira F; Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research 'Demokritos', Patriarchou Gregoriou & Neapoleos str., Aghia Paraskevi, Attiki, Athens, Greece.
Foulkes WD; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada.
Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan 52621, and Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel.
Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, United Kingdom.
Gaddam P; Clinical Cancer Genetics Laboratory, Memorial Sloane Kettering Cancer Center, New York, NY, United States of America.
Ganz PA; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, Room A2-125 HS, Los Angeles, CA 90095-6900, United States of America.
Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, United States of America.
Garcia-Barberan V; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain.
Gauthier-Villars M; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet 4062, Blegdamsvej 9, København Ø, Denmark.
Giraud S; Service de Génétique Moléculaire et Clinique, Hospices Civils de Lyon, Lyon cedex 04, France.
Godwin AK; Department of Pathology and Laboratory Medicine, 3901 Rainbow Boulevard, 4019 Wahl Hall East, MS 3040, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
Goldgar DE; Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT 84132, United States of America.
Hake CR; City of Hope Clinical Cancer Genetics Community Research Network, 1500 East Duarte Road, Duarte, CA 91010, United States of America.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Healey S; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
Hodgson S; Medical Genetics Unit, St George's, University of London, London, United Kingdom.
Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, P.O. Box 90203, 1000 BE, Amsterdam, The Netherlands.
Houdayer C; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
Hulick PJ; Center for Medical Genetics, NorthShore University Health System, University of Chicago Pritzker School of Medicine, 1000 Central Street, Suite 620, Evanston, IL 60201, United States of America.
Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg 197758, Russia.
Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC, United States of America.
Izatt L; Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Izquierdo A; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Av. França s/n. 1707 Girona, Spain.
Jacobs L; Clinical Genetics Research Laboratory, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, United States of America.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Santariskiu st., State Research Institute Centre for Innovative medicine, Zygymantu st. 9, Vilnius, Lithuania.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Brendstrupgaardsvej 21C, Aarhus N, Denmark.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, 2201 Walnut Avenue, Suite 300, Fremont, CA 94538, United States of America.
Vijai J; Clinical Genetics Research Laboratory, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10044, United States of America.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, United States of America.
Kast K; Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, P.O. BOX 700 (Haartmaninkatu 8), 00029 HUS, Finland.
Kwong A; The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong China.
Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan 52621, Israel.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, United States of America.
Lesueur F; Genetic Epidemiology of Cancer team, Inserm U900, Institut Curie, Mines ParisTech, 26 rue d'Ulm, 75248 Paris cedex 05, France.
Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
Mai PL; Clinical Genetics Branch, DCEG, NCI, NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, United States of America.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133 Milan, Italy.
Mazoyer S; Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, Lyon, France.
Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Mensenkamp AR; Department of Human Genetics, Radboud university medical centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, Padua, Italy.
Nathanson KL; Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, United States of America.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, United States of America.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, P.O. BOX 700 (Haartmaninkatu 8), 00029 HUS, Finland.
Niederacher D; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Olopade OI; The University of Chicago Medicine, 5841 South Maryland Avenue, MC 2115 Chicago, IL 60637.
Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom.
Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Department of Biomedical Science, Seoul National University Graduate School, and Cancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea.
Paulsson-Karlsson Y; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Pedersen IS; Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Reberbansgade 15, Aalborg, Denmark.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133 Milan, Italy.
Peterlongo P; IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, c/o IFOM-IEO campus, via Adamello 16, 20139 Milan, Italy.
Pfeiler G; Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America.
Piedmonte M; NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Elm St & Carlton St, Buffalo, NY 14263, United States of America.
Poppe B; Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000 Gent, Belgium.
Pujana MA; Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predicted Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), c/o Amaedeolab, via GA Amadeo 42, 20133 Milan, Italy.
Rennert G; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, 7 Michal St., Haifa 34362, Israel.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, Univ of Chicago, 2650 Ridge Avenue Suite 1507 Walgreens, Evanston, IL 60201, United States of America.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1000 BE, Amsterdam, The Netherlands.
Ross EA; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States of America.
Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
Singer CF; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria, and Waehringer Guertel 18-20, A 1090 Vienna, Austria.
Slavin TP; Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, California 91010, United States of America.
Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City (Quebec), Canada.
Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Stoppa-Lyonnet D; Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris Cedex 05, France.
Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland.
Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Szabo CI; National Human Genome Research Institute, National Institutes of Health, Building 50, Room 5312, 50 South Drive, MSC 004, Bethesda, MD 20892-8004, United States of America.
Tea MK; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria, and Waehringer Guertel 18-20, A 1090 Vienna, Austria.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS12/1A, Subang Jaya, 47500 Malaysia.
Terry MB; Department of Epidemiology, Columbia University, New York, NY, United States of America.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Sonder Boulevard 29, Odense C, Denmark.
Tibiletti MG; UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Via O.Rossi 9, 21100 Varese, Italy.
Tihomirova L; Latvian Biomedical Research and Study Centre, Ratsupites str 1, Riga, Latvia.
Tognazzo S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, Padua, Italy.
van Rensburg EJ; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Private Bag X323, Arcadia 0007, South Africa.
Varesco L; Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, largo Rosanna Benzi 10, 16132 Genoa, Italy.
Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
Vratimos A; Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research 'Demokritos' Patriarchou Gregoriou & Neapoleos str., Aghia Paraskevi, Attiki, Athens, Greece.
Weitzel JN; Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, California 91010, United States of America.
McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Kirk J; Westmead Hospital, Familial Cancer Service, Hawkesbury Road, P.O. Box 533, Wentworthville, NSW 2145, Australia.
Toland AE; Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, 998 Biomedical Research Tower, Columbus, OH, United States of America.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Lindor N; Department of Health Sciences Research, Mayo Clinic, 13400 E. Scottsdale Blvd., Scottsdale, AZ, United States of America.
Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, California, United States of America.
Greene MH; Clinical Genetics Branch, DCEG, NCI, NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, United States of America.
Couch FJ; Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, United States of America.
Offit K; Clinical Genetics Research Laboratory, Dept. of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10044, United States of America.
Pharoah PD; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, Australia, 4029.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Pokaż więcej
Corporate Authors:
KConFab Investigators; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia.
Źródło:
PloS one [PLoS One] 2016 Jul 27; Vol. 11 (7), pp. e0158801. Date of Electronic Publication: 2016 Jul 27 (Print Publication: 2016).
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Chromosomes, Human, Pair 9*
Genes, BRCA1*
Genes, BRCA2*
Genetic Carrier Screening*
Genetic Predisposition to Disease*
Ovarian Neoplasms/*genetics
Chromosome Mapping ; Female ; Humans ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Autorzy:
Blanco I; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Kuchenbaecker K; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Cuadras D; Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America.
Barrowdale D; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
de Garibay GR; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Librado P; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Sánchez-Gracia A; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Rozas J; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Bonifaci N; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
McGuffog L; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Islam A; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.
Mateo F; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Berenguer A; Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Petit A; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Català I; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain.
Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Tornero E; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Benítez J; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
Ramón y Cajal T; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Arun BK; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Toland AE; Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
Nussbaum RL; Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America.
Andrulis IL; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Domchek SM; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Nathanson KL; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Rebbeck TR; Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Barkardottir RB; Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Van Maerken T; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Díez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
Caldés T; Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
Dunning AM; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Oliver C; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Fineberg E; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Cook M; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Peock S; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
McCann E; All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom.
Murray A; All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom.
Jacobs C; Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Pichert G; Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Lalloo F; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
Chu C; Yorkshire Regional Genetics Service, Leeds, United Kingdom.
Dorkins H; North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom.
Paterson J; Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom.
Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.
van der Hout AH; Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Ligtenberg MJ; Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Wijnen JT; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meijers-Heijboer HE; Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands.
Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Aalfs CM; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America.
Phillips KA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
Piedmonte M; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Nerenstone SR; Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America.
Bae-Jump VL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
O'Malley DM; Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America.
Ratner ES; Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Schmutzler RK; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Wappenschmidt B; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Rhiem K; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Meindl A; Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Ditsch N; Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany.
Arnold N; Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
Plendl HJ; Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
Niederacher D; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Wang-Gohrke S; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Preisler-Adams S; Institute of Human Genetics, University of Münster, Münster, Germany.
Kast K; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Pedersen IS; Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Sunde L; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Peterlongo P; Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy.
Bernard L; Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Scuvera G; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Ottini L; Department of Molecular Medicine, 'Sapienza' University, Rome, Italy.
Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Agata S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Maugard C; Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
Soucy P; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
Berger A; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Fink-Retter A; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Rappaport C; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Geschwantler-Kaulich D; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tea MK; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pfeiler G; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.
Miron A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Terry MB; Department of Epidemiology, Columbia University, New York, New York, United States of America.
Chung WK; Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania.
Dorfling CM; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
van Rensburg EJ; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
Fostira F; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
Konstantopoulou I; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
Garber J; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Narod SA; Women's College Research Institute, University of Toronto, Toronto, Canada.
Rennert G; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.
Paluch SS; The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Loman N; Department of Oncology, Lund University Hospital, Lund, Sweden.
Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Spurdle AB; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Healey S; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Weitzel JN; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Herzog J; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Margileth D; St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America.
Gorrini C; The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada.
Esteller M; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.
Gómez A; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Sayols S; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Vidal E; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Heyn H; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Stoppa-Lyonnet D; Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Léoné M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
Barjhoux L; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Fassy-Colcombet M; Department of Tumour Biology, Institut Curie, Paris, France.
de Pauw A; Department of Tumour Biology, Institut Curie, Paris, France.
Lasset C; Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
Ferrer SF; Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France.
Castera L; Department of Tumour Biology, Institut Curie, Paris, France.
Berthet P; Centre François Baclesse, Caen, France.
Cornelis F; Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France.
Bignon YJ; Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France.
Damiola F; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Mazoyer S; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Sinilnikova OM; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Maxwell CA; Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.
Vijai J; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Robson M; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Kauff N; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Corines MJ; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Villano D; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Cunningham J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Lee A; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Lindor N; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Easton DF; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Offit K; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Chenevix-Trench G; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Antoniou AC; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Pujana MA; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Pokaż więcej
Corporate Authors:
Teixeira
BCFR
SWE-BRCA
kConFab Investigators
GEMO
Źródło:
PloS one [PLoS One] 2015 Apr 01; Vol. 10 (4), pp. e0120020. Date of Electronic Publication: 2015 Apr 01 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Genes, BRCA1*
Genes, BRCA2*
Mutation*
Breast Neoplasms/*genetics
Genetic Predisposition to Disease/*genetics
Aurora Kinase A/genetics ; Breast Neoplasms/enzymology ; Breast Neoplasms/pathology ; Carcinogenesis/genetics ; Cell Cycle Proteins/genetics ; Estrogen Receptor alpha/metabolism ; Evolution, Molecular ; Extracellular Matrix Proteins/genetics ; Female ; Genetic Loci/genetics ; Humans ; Hyaluronan Receptors/genetics ; Likelihood Functions ; Mammary Glands, Human/metabolism ; Microtubule-Associated Proteins/genetics ; Nuclear Proteins/genetics ; Polymorphism, Single Nucleotide ; Retrospective Studies ; Tubulin/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Autorzy:
Kuchenbaecker KB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Tyrer J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Shen HC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Beesley J; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Lawrenson K; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Healey S; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Lee JM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Spindler TJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Lin YG; Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA.
Pejovic T; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Bean Y; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Li Q; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Coetzee S; 1] Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. [2] Center for Cell-Based Therapy, Monte Alegre, Ribeirão Preto, Brazil. [3] Center for Integrative Systems Biology, Monte Alegre, Ribeirão Preto, Brazil.
Hazelett D; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
Miron A; Department of Genomics and Genome Sciences, Case Western Reserve University Medical School, Cleveland, Ohio, USA.
Southey M; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Terry MB; Department of Epidemiology, Columbia University, New York, New York, USA.
Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Buys SS; Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Janavicius R; 1] Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medical Center, Vilinius University Hospital Santariskiu Clinics, Vilnius, Lithuania, Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. [2] State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa.
van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Dennis J; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2] Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Benitez J; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Human Genotyping Unit (CEGEN), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [3] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Osorio A; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Garcia MJ; 1] Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. [2] Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Komenaka I; Maricopa Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Weitzel JN; Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Ganschow P; Cook County Health and Hospital System, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
Peterlongo P; Fondazione Istituto FIRC (Italian Foundation for Cancer Research) di Oncologia Molecolare (IFOM), Milan, Italy.
Bernard L; 1] Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. [2] Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Viel A; Division of Experimental Oncology, CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute, Aviano, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico (Italian Research Hospital)) Istituto Nazionale Tumori (INT), Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy.
Papi L; Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
Ottini L; Department of Molecular Medicine, University La Sapienza, Rome, Italy.
Fostira F; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Perkins J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Platte R; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Schmutzler RK; 1] Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany. [2] Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany. [3] Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. [4] On behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC).
Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Sutter C; Institute of Human Genetics, University Heidelberg, Heidelberg, Germany.
Sinilnikova OM; 1] INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. [2] Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
Damiola F; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Mazoyer S; INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Stoppa-Lyonnet D; 1] Institut Curie, Department of Tumour Biology, Paris, France. [2] Institut Curie, INSERM U830, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
De Leeneer K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Kirk J; Australia New Zealand Gynecologic Oncology Group (ANZGOG) and Familial Cancer Service, Westmead Hosptial, Sydney, New South Wales, Australia.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Piedmonte M; Gynecologic Oncology Group, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, USA.
O'Malley DM; James Cancer Center, Ohio State University, Columbus, Ohio, USA.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oosterwijk JC; Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands.
Tihomirova L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Hamann U; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Isaccs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Tischkowitz M; Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada.
Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
Caligo MA; Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy.
Campbell IG; VBCRC (Victorian Breast Cancer Research Consortium) Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Diez O; Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain.
Blanco I; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute)-Catalan Institute of Oncology, Barcelona, Spain.
Brunet J; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona)-Catalan Institute of Oncology, Girona, Spain.
Lazaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Pujana MA; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Barkardottir RB; Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Plante M; Gynaecologic Oncology Service, Centre Hospitalier Universitaire de Québec (CHUQ), Quebec City, Quebec, Canada.
Simard J; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
Soucy P; Centre Hospitalier Universitaire de Québec (CHUQ) Research Center, Laval University, Quebec City, Quebec, Canada.
Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
Tognazzo S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV)-IRCCS, Padua, Italy.
Teixeira MR; 1] Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. [2] Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Lindor N; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Szabo CI; National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA.
Kauff N; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Vijai J; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Aghajanian CA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Pfeiler G; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Berger A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tea MK; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Rennert G; Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Mulligan AM; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Andrulis IL; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, USA.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Zidan J; Institute of Oncology, Rivka Ziv Medical Center, Zefat, Israel.
Friedman E; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
Laitman Y; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Aviv, Israel.
Soller M; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Arver B; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Einbeigi Z; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA.
Nussbaum RL; Department of Medicine and Genetics, University of California, San Francisco, San Francisco, California, USA.
Rebbeck TR; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nathanson KL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Domchek SM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lu KH; Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Hein A; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
Beckmann MW; Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany.
Fasching PA; 1] Department of Obstetrics and Gynecology, Erlangen University Hospital, University of Erlangen-Nuremberg, Erlangen, Germany. [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Lambrechts D; 1] Vesalius Research Center, VIB, Leuven, Belgium. [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Van Nieuwenhuysen E; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Vergote I; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Lambrechts S; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, Belgium.
Dicks E; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Doherty JA; Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
Wicklund KG; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rossing MA; 1] Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wang-Gohrke S; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Sucheston L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Lele S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Goodman MT; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Thompson PJ; 1] Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. [2] Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Runnebaum IB; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Dürst M; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Hillemanns P; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Antonenkova N; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus.
Bogdanova N; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Leminen A; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Butzow R; 1] Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. [2] Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland.
Modugno F; 1] Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [3] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [4] Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
Kelley JL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Edwards RP; 1] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. [2] Ovarian Cancer Center of Excellence, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ness RB; University of Texas School of Public Health, Houston, Texas, USA.
du Bois A; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Heitz F; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Schwaab I; Institut für Humangenetik Wiesbaden, Wiesbaden, Germany.
Harter P; 1] Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany. [2] Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Kjaer SK; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Hogdall E; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. [2] Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Hasmad HN; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia.
Azmi MA; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Teo SH; 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Woo YL; 1] Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. [2] University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Fridley BL; Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, USA.
Goode EL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
Hildebrandt MA; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wu X; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina, USA.
Schildkraut JM; 1] Cancer Control and Population Sciences, Duke Cancer Institute, Durham, North Carolina, USA. [2] Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Concannon P; 1] Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA. [2] Genetics Institute, University of Florida, Gainesville, Florida, USA.
Weber RP; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Cramer DW; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Terry KL; 1] Harvard School of Public Health, Boston, Massachusetts, USA. [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Poole EM; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Tworoger SS; 1] Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Orlow I; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Olson SH; Department of Epidemiology and Biostatistics, Epidemiology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Krakstad C; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Salvesen HB; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Tangen IL; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Bjorge L; 1] Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway. [2] Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
van Altena AM; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Aben KK; 1] Comprehensive Cancer Center The Netherlands, Utrecht, the Netherlands. [2] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.
Kiemeney LA; 1] Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands. [2] Department of Urology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Massuger LF; Department of Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Kellar M; 1] Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA. [2] Knight Cancer Institute, Portland, Oregon, USA.
Brooks-Wilson A; 1] Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. [2] Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
Kelemen LE; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Le ND; Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Clinic of Opthalmology, Pomeranian Medical University, Szczecin, Poland.
Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Lissowska J; Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Hogdall C; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lundvall L; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Nedergaard L; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Baker H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
McNeish I; Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
Paul J; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Carty K; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
Glasspool R; Cancer Research UK Clinical Trials Unit, Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
Whittemore AS; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Rothstein JH; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
McGuire V; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Sieh W; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
Ji BT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Zheng W; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shu XO; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Gao YT; Shanghai Cancer Institute, Shanghai, China.
Rosen B; 1] Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. [2] Department of Gynecologic-Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
McLaughlin JR; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Narod SA; Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Chen A; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Lin HY; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Tsai YY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Chen Z; Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida, USA.
Ziogas A; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
Anton-Culver H; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
Gentry-Maharaj A; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
Menon U; Women's Cancer, University College London Elizabeth Garrett Anderson (EGA) Institute for Women's Health, London, UK.
Harrington P; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Lee AW; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Coetzee G; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Urology, University of Southern California, Los Angeles, California, USA.
Pike MC; 1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA. [2] Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Dansonka-Mieszkowska A; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Timorek A; Department of Obstetrics, Gynecology and Oncology, 2nd Faculty of Medicine, Warsaw Medical University and Brodnowski Hospital, Warsaw, Poland.
Rzepecka IK; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Kupryjanczyk J; Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Freedman M; Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Noushmehr H; Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Offit K; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Couch FJ; 1] Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. [2] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Gayther S; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pharoah PP; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Chenevix-Trench G; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Pokaż więcej
Corporate Authors:
EMBRACE
GEMO Study Collaborators
Breast Cancer Family Registry
HEBON
KConFab Investigators
Australian Cancer Study (Ovarian Cancer Investigators)
Australian Ovarian Cancer Study Group
Consortium of Investigators of Modifiers of BRCA1 and BRCA2
Źródło:
Nature genetics [Nat Genet] 2015 Feb; Vol. 47 (2), pp. 164-71. Date of Electronic Publication: 2015 Jan 12.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Genome-Wide Association Study/*methods
Neoplasms, Glandular and Epithelial/*genetics
Ovarian Neoplasms/*genetics
Adolescent ; Adult ; Alleles ; Carcinoma, Ovarian Epithelial ; Female ; Genes, Reporter ; Genotype ; Heterozygote ; Humans ; Mutation ; Quantitative Trait Loci ; Risk ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 43

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies